Clinical Trial

Brain Stimulation to the Hippocampus in Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Summary
Schizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely contributes to schizophrenia symptoms, but to develop better therapies we need to understand whether hippocampal activity in schizophrenia can be systematically affected by non-invasive brain stimulation techniques like transcranial magnetic stimulation (TMS). This proposal will investigate the use of connectivity-guided theta burst brain stimulation to specifically target hippocampal function in schizophrenia, offering insights into fundamental hippocampal processes, schizophrenia pathophysiology, and potential avenues to use brain stimulation as a therapeutic tool in this devastating illness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-30.
Status change: Not Yet Recruiting → Recruiting 2026-02-25
Trial Details
NCT Number NCT07010614
Lead Sponsor Stanford University
Collaborators: National Institute of Mental Health (NIMH)
Conditions Schizophrenia Disorders, Mental Disorder, Psychotic Disorder
Enrollment 60 participants
Start Date 2025-10-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-27